-
The FDA has recently approved adefovir dipivoxil for the treatment of chronic hepatitis B in adults. This prodrug of adefovir is a nucleotide analog that was originally developed for the treatment of HIV infections but has also been found to be active against the hepatitis B virus.
-
Effects of Long-Term Treatment With ACE Inhibitors in the Presence or Absence of Aspirin; Long-Term Risks Associated with Atrial Fibrillation: 20-Year Follow-up of the Renfrew/Paisley Study; Olfactory
Impairment in Older Adults
-
The 12-lead ECG and accompanying rhythm strip in the Figure were obtained from an 84-year-old man who presented to the Emergency Department with acute dyspnea from pneumonia and heart failure. Can you account for the relatively slow heart rate despite his acute shortness of breath?
-
The FDA has approved the first generic version of AstraZeneca plcs blockbuster drug, omeprazole (Prilosec).
-
-
This study suggests that high-dose rofecoxib may increase the risk of cardiovascular events.
-
The quintet of abdominal obesity, hypertension, dyslipidemia, abnormal glucose metabolism, and coagulopathy has been called syndrome X or metabolic syndrome. Some have referred to this grouping as the insulin resistance syndrome, the obesity dyslipidemia syndrome, and the deadly quartet.
-
-
The primary care physician who cares for couples in their childbearing years should encourage women and their partners to receive preconception care. The physician can enhance this opportunity by adopting a preconception focus during annual medical exams and asking the patients about their conception plans.
-
FDA Approves Generic Version of AstraZenecas Prilosec; Pegasys
Approved To Treat Hepatitis C; HRT Reduces Alzheimers Risk, Study
Says; Heparin Plus Alteplase More Effective; Digoxin Effects Differ By
Sex; McClellan Named FDA Commissioner; FDA Actions
